The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.

Typeset version

 

TY  - JOUR
  - Shields DC, Fitzgerald AP, O'Neill PA, Muckian C, Kenny D, Moran B, Cannon CP, Byrne CE, Fitzgerald DJ.
  - 2002
  - March
  - Pharmacogenomics
  - The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.
  - Published
  - ()
  - Pharmagenomics J; 2
  - 3
  - 182
  - 190
DA  - 2002/03
ER  - 
@article{V352283,
   = {Shields DC,  Fitzgerald AP and  O'Neill PA,  Muckian C and  Kenny D,  Moran B and  Cannon CP,  Byrne CE and  Fitzgerald DJ. },
   = {2002},
   = {March},
   = {Pharmacogenomics},
   = {The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.},
   = {Published},
   = {()},
   = {Pharmagenomics J; 2},
   = {3},
  pages = {182--190},
  source = {IRIS}
}
AUTHORSShields DC, Fitzgerald AP, O'Neill PA, Muckian C, Kenny D, Moran B, Cannon CP, Byrne CE, Fitzgerald DJ.
YEAR2002
MONTHMarch
JOURNAL_CODEPharmacogenomics
TITLEThe contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.
STATUSPublished
TIMES_CITED()
SEARCH_KEYWORD
VOLUMEPharmagenomics J; 2
ISSUE3
START_PAGE182
END_PAGE190
ABSTRACT
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS